We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+14.66%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.8B
AUM Growth
+$1.57B
Cap. Flow
+$1.41B
Cap. Flow %
78.35%
Top 10 Hldgs %
44.86%
Holding
45
New
4
Increased
33
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$80M
2
EXPE icon
Expedia Group
EXPE
+$76.1M
3
OMF icon
OneMain Financial
OMF
+$73.1M
4
C icon
Citigroup
C
+$63.6M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$63.5M

Top Sells

Rank Stock Value
1
QUOT
Quotient Technology Inc
QUOT
+$2.69M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.59M
3
ADT icon
ADT
ADT
+$1.39M
4
RKT icon
Rocket Companies
RKT
+$131K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.24%
2 Financials 22.56%
3 Industrials 10.69%
4 Communication Services 10.27%
5 Energy 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
26
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$38.3M 2.13%
176,826
+153,451
+656% +$32.9M
SOFI icon
27
SoFi Technologies
SOFI
$23.3B
$37M 2.06%
4,435,864
+3,966,164
+844% +$25.9M
FISV
28
Fiserv Inc
FISV
$27.5B
$36.5M 2.03%
289,609
+236,184
+442% +$27.8M
CLF icon
29
Cleveland-Cliffs
CLF
$6.99B
$33.4M 1.86%
1,991,307
+1,732,982
+671% +$27.5M
TMHC
30
DELISTED
Taylor Morrison
TMHC
$29M 1.61%
594,402
+416,727
+235% +$17.9M
PTON icon
31
Peloton Interactive
PTON
$2.39B
$21.7M 1.21%
2,817,528
+2,486,803
+752% +$21.1M
WAL icon
32
Western Alliance Bancorporation
WAL
$8.9B
$16.1M 0.9%
+441,407
New +$15.3M
PGEN icon
33
Precigen
PGEN
$2.54B
$12.9M 0.72%
11,243,560
+9,779,800
+668% +$11.5M
RKT icon
34
Rocket Companies
RKT
$37.9B
$4.41M 0.25%
492,600
-15,100
-3% -$131K
SFIX
35
Stitch Fix
SFIX
$554M
$3.3M 0.18%
856,900
+218,800
+34% +$829K
DXC icon
36
DXC Technology
DXC
$1.74B
$2.75M 0.15%
102,850
+42,850
+71% +$1.07M
TEVA icon
37
Teva Pharmaceuticals
TEVA
$40.9B
$2.3M 0.13%
306,054
-319,946
-51% -$2.59M
LEN.B icon
38
Lennar Class B
LEN.B
$20.5B
$1.41M 0.08%
13,150
– –
FANG icon
39
Diamondback Energy
FANG
$52.8B
$1.31M 0.07%
10,000
– –
VNT icon
40
Vontier
VNT
$4.96B
$1.29M 0.07%
40,000
– –
BAC icon
41
Bank of America
BAC
$440B
$717K 0.04%
25,000
– –
ADT icon
42
ADT
ADT
$5.57B
$603K 0.03%
100,000
-222,300
-69% -$1.39M
BRLT icon
43
Brilliant Earth
BRLT
$20.5M
$199K 0.01%
+51,368
New +$195K
QUOT
44
DELISTED
Quotient Technology Inc
QUOT
– –
-819,400
Closed -$2.69M
1
2

Similar funds

CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Patient Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Patient Capital Management held 45 positions worth $1.8B, up 701% from $224M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Patient Capital Management deployed $1.41B of net new capital in Q2 2023, opening 4 new positions and adding to 33 existing holdings. Its largest new stake was People Inc: 834,615 shares worth $43M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, down from 35% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $2.59M trimmed.

  • Patient Capital Management's largest Q2 2023 buy was People Inc: 834,615 shares worth $43M.
  • Patient Capital Management added most to Amazon in Q2 2023, an estimated $80M increase.
  • Patient Capital Management's biggest Q2 2023 reduction was Teva Pharmaceuticals, cutting an estimated $2.59M.
  • Patient Capital Management fully exited Quotient Technology Inc in Q2 2023, selling an estimated $2.69M.
  • Patient Capital Management's ten largest holdings make up 45% of its $1.8B portfolio in Q2 2023.
  • Patient Capital Management opened 4 new positions and closed 1 in Q2 2023.
  • Patient Capital Management's portfolio value rose 701% quarter-over-quarter to $1.8B.

Based on Patient Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.